Cancer/Cell Phone Connection Challenged
In the letter, Davis and Balzano, who each have more than 35 years of research experience in the biological effects of wireless telecommunications technology, offered a critique of a paper…
Botox May Dampen Emotions
@ballyscanlon, Getty Images@ballyscanlon, Getty ImagesA recent article in Forbes cited a study in the journal Social Psychology and Personality Science that found that Botox may not only numb facial muscles,…
CMS Reports on Provider Performance
The next step in the process of releasing more information about the performance of hospitals and physicians (as noted previously) has been taken by CMS. The next step in the process…
Health Care Buzz Today
HIV Cases Fall by 25% between 2001-1009. The data comes from a press release by the Joint United Nations Programme on HIV/AIDS. Researchers attribute the drop to safer sex behaviors…
Mazor Spinal Robot Receives Both FDA and European CE Approval (Video)
At $500,000 for the machine it is not cheap by all means and the price in the last year just went up. The machine makes much of spine surgery minim…
Social Media in Health Care: It’s Happening … It Works … It’s the *Message*
Warning… this is not going to be a mind blowing post … but this a message that bears repeating. This is also a message that should resonate loud and clear…
Sutures, staples, clips in wound closure
Our regular coverage of developments in the field of surgical sealants, hemostasis, wound closure and anti-adhesion, most recently through Report #S180, entails the full potential caseload of patients targeted by…
Why One Navy Medical Officer Loves Family Medicine
I’ve been a leader all my life, from Swim Team Captain, to Student Council President, to being a lead physician of our Navy Special Operations Team. I want to continue…
Leave Well Enough Alone
A report by National Physicians Alliance (NPA), published in the Archives of Internal Medicine, advises Americans to get less health care: A report by National Physicians Alliance (NPA), published in the Archives…
OXiGENE Releases Promising Phase Two Data For Lung Cancer Drug
OXiGENE (NASDAQ:OXGN) shares rose in pre-market trading on Monday as it announced on the weekend that follow-up results from a phase two study of Zybrestat showed that patients with non-small…
